Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.93
-$1.99-10.50%
| Weiss Ratings | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C+ | |||
| Rating Factors | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Weak | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.11 | |||
| Price History | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -15.19% | |||
| 60-Day Total Return | -34.65% | |||
| 90-Day Total Return | -16.17% | |||
| Year to Date Total Return | -34.65% | |||
| 1-Year Total Return | 10.82% | |||
| 2-Year Total Return | 11.26% | |||
| 3-Year Total Return | 0.55% | |||
| 5-Year Total Return | -10.41% | |||
| 52-Week High % Change | -34.65% | |||
| 52-Week Low % Change | 8.27% | |||
| Price | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $25.91 | |||
| 52-Week Low Price | $15.64 | |||
| 52-Week Low Price (Date) | Apr 10, 2024 | |||
| 52-Week High Price (Date) | Dec 04, 2024 | |||
| Valuation | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.46B | |||
| Enterprise Value | 11.48B | |||
| Price/Earnings (TTM) | 92.03 | |||
| Earnings Per Share (TTM) | 0.18 | |||
| Earnings Per Share Growth | -33.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 8.68 | |||
| Price/Book (Q) | 8.08 | |||
| Enterprise Value/Revenue (TTM) | 9.58 | |||
| Price | $16.93 | |||
| Enterprise Value/EBITDA (TTM) | 34.69 | |||
| Enterprise Value/EBIT | 43.24 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 589.39M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 69.51% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 64 9 574 0100 | |||
| Address | -- | |||
| Website | www.fphcare.com | |||
| Country | New Zealand | |||
| Year Founded | 1934 | |||
| Profitability | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 22.16% | |||
| Profit Margin | 9.44% | |||
| Management Effectiveness | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 10.66% | |||
| Return on Equity | 9.52% | |||
| Income Statement | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.15B | |||
| Total Revenue (TTM) | 1.15B | |||
| Revenue Per Share | $1.95 | |||
| Gross Profit (TTM) | 697.66M | |||
| EBITDA (TTM) | 317.57M | |||
| EBIT (TTM) | 254.79M | |||
| Net Income (TTM) | 108.57M | |||
| Net Income Avl. to Common (TTM) | 108.57M | |||
| Total Revenue Growth (Q YOY) | 19.61% | |||
| Earnings Growth (Q YOY) | 44.29% | |||
| EPS Diluted (TTM) | 0.18 | |||
| EPS Diluted Growth (Q YOY) | 42.73% | |||
| Balance Sheet | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 74.21M | |||
| Cash Per Share (Q) | $0.13 | |||
| Total Current Assets (Q) | 488.70M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.23B | |||
| Current Ratio (Q) | 2.059 | |||
| Book Value Per Share (Q) | $2.10 | |||
| Total Assets (Q) | 1.55B | |||
| Total Current Liabilities (Q) | 237.32M | |||
| Total Debt (Q) | 96.04M | |||
| Total Liabilities (Q) | 321.77M | |||
| Total Common Equity (Q) | 1.23B | |||
| Cash Flow | FSPKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -72.14M | |||
| Cash from Financing (TTM) | -201.88M | |||
| Net Change in Cash (TTM) | 31.57M | |||
| Levered Free Cash Flow (TTM) | 184.27M | |||
| Cash from Operations (TTM) | 307.84M | |||
